Loading...

Illumina, Inc.

ILMNNASDAQ
Healthcare
Medical - Diagnostics & Research
$94.66
$-8.05(-7.84%)

Illumina, Inc. (ILMN) Stock Overview

Explore Illumina, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 73.2/100

Key Financials

Market Cap15B
P/E Ratio11.96
EPS (TTM)$-6.08
ROE0.53%
Fundamental Analysis

AI Price Forecasts

1 Week$83.53
1 Month$82.48
3 Months$108.12
1 Year Target$81.53

ILMN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Illumina, Inc. (ILMN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 42.62, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $81.53.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 11.96 and a market capitalization of 15B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;